These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8837768)

  • 21. Expression of protein zero is increased in lesioned axon pathways in the central nervous system of adult zebrafish.
    Schweitzer J; Becker T; Becker CG; Schachner M
    Glia; 2003 Feb; 41(3):301-17. PubMed ID: 12528184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelin basic protein gene dosage effects in the PNS.
    Smith-Slatas C; Barbarese E
    Mol Cell Neurosci; 2000 Apr; 15(4):343-54. PubMed ID: 10845771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.
    Menichella DM; Arroyo EJ; Awatramani R; Xu T; Baron P; Vallat JM; Balsamo J; Lilien J; Scarlato G; Kamholz J; Scherer SS; Shy ME
    Mol Cell Neurosci; 2001 Dec; 18(6):606-18. PubMed ID: 11749037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The different forms of PNS myelin P0 protein within and outside lipid rafts.
    Fasano A; Amoresano A; Rossano R; Carlone G; Carpentieri A; Liuzzi GM; Pucci P; Riccio P
    J Neurochem; 2008 Oct; 107(1):291-301. PubMed ID: 18680558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
    Nowakowski A; Kochański A
    Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel method for studying myelination in vivo reveals that EDTA is a potent inhibitor of myelin protein and mRNA expression during development of the rat sciatic nerve.
    Meintanis S; Thomaidou D; Jessen KR; Mirsky R; Matsas R
    Glia; 2004 Nov; 48(2):132-44. PubMed ID: 15378656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common themes in peripheral neuropathy disease genes.
    Snipes GJ; Orfali W
    Cell Biol Int; 1998 Nov; 22(11-12):815-35. PubMed ID: 10873294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
    Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
    J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
    Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
    Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The absence of myelin P0 protein produces a novel molecular phenotype in Schwann cells.
    Menichella DM; Xu W; Jiang H; Sohi J; Vallat JM; Baron P; Kamholz J; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():281-93. PubMed ID: 10586253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depleting endogenous neurotrophin-3 enhances myelin formation in the Trembler-J mouse, a model of a peripheral neuropathy.
    Liu N; Varma S; Tsao D; Shooter EM; Tolwani RJ
    J Neurosci Res; 2007 Oct; 85(13):2863-9. PubMed ID: 17628499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis.
    Harauz G; Ishiyama N; Hill CM; Bates IR; Libich DS; Farès C
    Micron; 2004; 35(7):503-42. PubMed ID: 15219899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neurotrophin receptor p75NTR as a positive modulator of myelination.
    Cosgaya JM; Chan JR; Shooter EM
    Science; 2002 Nov; 298(5596):1245-8. PubMed ID: 12424382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral neuropathies caused by mutations in the myelin protein zero.
    Shy ME
    J Neurol Sci; 2006 Mar; 242(1-2):55-66. PubMed ID: 16414078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelin mutants: model systems for the study of normal and abnormal myelination.
    Griffiths IR
    Bioessays; 1996 Oct; 18(10):789-97. PubMed ID: 8885716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
    Eggers SD; Keswani SC; Melli G; Cornblath DR
    Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells.
    Plaisier E; Mougenot B; Verpont MC; Jouanneau C; Archelos JJ; Martini R; Kerjaschki D; Ronco P
    J Am Soc Nephrol; 2005 Nov; 16(11):3350-6. PubMed ID: 16162811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A developmental study of the relationship between the protein components of rat CNS myelin.
    Adams DH; Osborne J
    Neurobiology; 1973; 3(2):91-112. PubMed ID: 16100958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palmitoylation of myelin P0 protein is independent of its synthesis and parallels that of phospholipids.
    Melendez RF; Bizzozero OA
    J Peripher Nerv Syst; 1996; 1(1):34-41. PubMed ID: 10970118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence of myelination in the human fetus.
    Gilles FH; Dooling E; Fulchiero A
    Trans Am Neurol Assoc; 1976; 101():244-6. PubMed ID: 1028249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.